Erika Ayers Badan: You Are The Problem (And The Solution)
This is an episode for people grappling with how to manage and how to embrace AI. Good managers in the future will seamlessly balance being…
Thought Leader: Erika Ayers Badan
When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like.
Erika Ayers Badan: You Are The Problem (And The Solution)
This is an episode for people grappling with how to manage and how to embrace AI. Good managers in the future will seamlessly balance being…
Thought Leader: Erika Ayers Badan
Patrick McGee: Tesla’s Robotaxi Bait and Switch
Elon Musk called self-driving cars a ‘solved problem’ 10 years ago. So how come he’s still working on it? In a new column, Patrick McGee…
Thought Leader: Patrick McGee
Mike Pence on U.S. Leadership and Global Strategy
Former Vice President of the United States, Mike Pence, shares his thoughts about President Trump’s framework on trying to acquire Greenland, and discusses what he…
Thought Leader: Mike Pence